Neonatal & Pediatric Pharmacology

Neonatal and Pediatric Pharmacology provides evidence-based guidelines for safe, effective, and rational drug therapy in new-borns, children, and adolescents.

Current research and clinical practice include specific recommendations for all major drug classes and diseases, specific treatment settings such as the pediatric intensive care unit and emergency room.

It also includes adverse effects and interactions and state-of-the-art discussions on pharmacokinetics, pharmacodynamics, pharmacogenetics, pharmacogenomics, pharmacoproteomic, drug development, and clinical trials in infants and children.

It also includes updated information on drug interactions and regulatory issues. It also covers nutrient supplements and biotransformation of medications by the human placenta.

  • Clinical Pharmacokinetics
  • Pharmacogenetics
  • Clinical trials involving children
  • Ethics of drug research in pediatric populations
  • Treatment settings such as the pediatric intensive care unit and emergency room.
  • Adverse effects and interactions
  • Drug development in infants and children
  • Drug development in infants and children

Related Conference of Neonatal & Pediatric Pharmacology

Neonatal & Pediatric Pharmacology Conference Speakers